Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease

ClinicalTrials.gov ID: NCT05496374

Public ClinicalTrials.gov record NCT05496374. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Investigator-Blinded, Placebo-Controlled, Multicenter, Phase 2, Dose-Ranging Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease

Study identification

NCT ID
NCT05496374
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Spero Therapeutics
Industry
Enrollment
25 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • SPR720 500 mg Drug
  • SPR720 1000 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 13, 2022
Primary completion
Oct 7, 2024
Completion
Dec 1, 2024
Last update posted
Oct 8, 2025

2022 – 2024

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Medical Facility Birmingham Alabama 35233
Medical Facility Fresno California 93701
Medical Facility Los Angeles California 90033
Medical Facility Newport Beach California 92663
Medical Facility Northridge California 91324
Medical Facility Santa Clarita California 91355
Medical Facility Washington D.C. District of Columbia 20007
Medical Facility Kissimmee Florida 34746-4654
Medical Facility Loxahatchee Groves Florida 33470
Medical Facility Miami Florida 33136
Medical Facility Sebring Florida 33870
Medical Facility Tampa Florida 33606
Medical facility Atlanta Georgia 30342
Medical Facility Iowa City Iowa 52242
Medical Facility Kansas City Kansas 66103
Medical Facility New Bedford Massachusetts 02740
Medical Facility Rochester Minnesota 55905
Medical Facility Lebanon New Hampshire 03756
Medical Facility New Hyde Park New York 11042
Medical Facility Chapel Hill North Carolina 27599
Medical Facility Winston-Salem North Carolina 27103
Medical Facility Cleveland Ohio 44106
Medical Facility Portland Oregon 97239
Medical Facility Pittsburgh Pennsylvania 15213
Medical Facility Charleston South Carolina 29425
Medical Facility Denison Texas 75020
Medical Facility Sherman Texas 75090
Medical Facility Tyler Texas 75708

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05496374, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05496374 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →